What is the recommended treatment for a patient with suspected peritonitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Suspected Peritonitis

Patients with suspected peritonitis require immediate broad-spectrum antibiotics within 1 hour (especially if septic shock is present) and emergency surgical intervention to drain infected foci and control peritoneal contamination. 1

Immediate Resuscitation and Initial Management

  • Initiate aggressive fluid resuscitation immediately to enhance visceral perfusion and address volume depletion in all patients with peritonitis 1
  • Administer broad-spectrum antibiotics as soon as possible, ideally within 1 hour for patients with septic shock, before any surgical intervention 1
  • Empiric antibiotic therapy must target Gram-negative, Gram-positive, and anaerobic bacteria given the polymicrobial nature of peritonitis 1

Distinguishing Secondary from Spontaneous Bacterial Peritonitis

This distinction is critical because unnecessary laparotomy in cirrhotic patients increases mortality, while delayed surgery in secondary peritonitis is fatal 2:

Suspect secondary bacterial peritonitis when:

  • PMN count >1,000/mm³ (rather than the typical >250/mm³ for spontaneous bacterial peritonitis) 2
  • Multiple organisms seen on Gram stain or culture 2
  • Ascitic total protein ≥1 g/dL 2
  • Ascitic LDH above normal serum upper limit 2
  • Ascitic glucose ≤50 mg/dL 2
  • PMN count fails to drop after 48 hours of antibiotic treatment 2
  • Elevated ascitic CEA (>5 ng/mL) or alkaline phosphatase (>240 U/L) suggesting intestinal perforation 2

If secondary bacterial peritonitis is suspected, perform abdominal CT scanning immediately and proceed to early surgical intervention 2

Empiric Antibiotic Selection

For Community-Acquired Peritonitis (Non-Critically Ill):

  • Piperacillin/tazobactam is the recommended first-line agent for non-critically ill, immunocompetent patients with adequate source control 1
  • Alternative regimens include cefotaxime 2 g every 6-8 hours IV or ceftriaxone 1 g every 12-24 hours IV 2
  • Amoxicillin-clavulanic acid shows similar resolution rates to cefotaxime but has concerns for drug-induced liver injury 2

For High-Risk or Critically Ill Patients:

  • For patients at high risk of ESBL-producing Enterobacterales, use ertapenem or eravacycline 1
  • For septic shock, use meropenem, doripenem, imipenem/cilastatin, or eravacycline 1
  • Carbapenems should be reserved for nosocomial cases, healthcare-associated infections, or recent broad-spectrum antibiotic exposure 3

Coverage Considerations:

  • Avoid aminoglycosides as empirical therapy due to nephrotoxicity 2
  • Antifungal therapy (fluconazole) is recommended for hospital-acquired infections and critically ill or severely immunocompromised patients 1

Surgical Management

Emergency surgical intervention should be performed as soon as possible in patients with diffuse peritonitis, even if physiologic stabilization measures need to continue during the procedure 1:

  • The primary surgical goals are to drain infected foci, control ongoing peritoneal contamination, and restore anatomic and physiological function 1
  • For perforated diverticulitis with diffuse peritonitis, Hartmann's procedure is recommended in critically ill patients 1
  • Inadequate source control is the most common reason for treatment failure 3
  • Delay in surgical control significantly increases mortality 3

Duration of Antibiotic Therapy

For patients with adequate source control, use a short course of 3-5 days of antibiotic therapy 1:

  • For immunocompromised or critically ill patients with adequate source control, extend antibiotic therapy up to 7 days 1, 3
  • Duration can be shortened if PMN count in peritoneal fluid decreases to <250/mm³ before day 5-7 3
  • Perform follow-up paracentesis at 48 hours to evaluate response; a decrease in PMN count <25% of baseline indicates treatment failure 3

Monitoring and Re-evaluation

  • Serial assessment of inflammatory markers (CRP, procalcitonin, WBC) guides duration decisions 3
  • Clinical improvement should be evident within 48-72 hours of appropriate therapy and source control 3
  • Lack of improvement warrants re-evaluation for resistant organisms or inadequate source control 3
  • Patients with ongoing signs of infection beyond 7 days require diagnostic re-evaluation and multidisciplinary assessment 3

Special Considerations for Spontaneous Bacterial Peritonitis in Cirrhosis

If spontaneous bacterial peritonitis is suspected and PMN count is >250/mm³, start empirical antibiotics immediately regardless of culture results 2:

  • Even with PMN <250/mm³, if symptoms or signs of infection are present (temperature >37.8°C, abdominal pain or tenderness), administer empirical antibiotics until culture results are available 2
  • Standard treatment duration is 5-10 days, adjusted according to symptoms and antimicrobial susceptibility results 2
  • Oral ofloxacin has shown similar results to IV cefotaxime in uncomplicated SBP without renal failure, hepatic encephalopathy, GI bleeding, ileus, or shock 2

Common Pitfalls to Avoid

  • Do not perform unnecessary laparotomy in cirrhotic patients with spontaneous bacterial peritonitis, as this increases mortality 2
  • Do not use prolonged courses of broad-spectrum antibiotics empirically in patients with persistent inflammation without searching for new infection sources, as this promotes multidrug-resistant organisms 4
  • Previous broad-spectrum antibiotic exposure is the most important risk factor for multidrug-resistant organisms in postoperative peritonitis 3
  • On-demand re-laparotomy is recommended for severe peritonitis rather than planned re-laparotomy, as it streamlines resources and reduces costs 1

References

Guideline

Treatment of Peritonitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Duration of Carbapenem Treatment for Secondary Peritonitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Antibiotics for the acute abdomen.

The Surgical clinics of North America, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.